Short description
Drug Discovery and Biotechnology
Description
Capienda saves time (1-2 yrs) and cost ($1 Billion) to develop new medicines by opening a key bottleneck in drug discovery.
Capienda provides missing results for better small molecule designs: higher quality drugs enter clinical trials.
* First high-throughput kinetics system for small molecule drugs.
* 48x throughput of Biacore.
* Specialist scientists not required.
Product is laboratory instrument system + assay chemicals (recurring revenues).
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Carlsbad, California, United States, North America
Founded on
October 5, 2017
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Investors
Absolutely Noaccess
Sign in for full access
Founders
Mark Bernard